TScan Therapeutics, Inc. (TCRX)

TScan Therapeutics Statistics

Total Valuation

TCRX has a market cap or net worth of $76.40 million. The enterprise value is -$116.33 million.

Market Cap	76.40M
Enterprise Value	-116.33M

Important Dates

The last earnings date was Wednesday, March 5, 2025, before market open.

Earnings Date	Mar 5, 2025
Ex-Dividend Date	n/a

Share Statistics

TCRX has 56.59 million shares outstanding. The number of shares has increased by 18.32% in one year.

Current Share Class	52.31M
Shares Outstanding	56.59M
Shares Change (YoY)	+18.32%
Shares Change (QoQ)	+6.07%
Owned by Insiders (%)	0.77%
Owned by Institutions (%)	50.44%
Float	37.14M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	27.13
Forward PS	15.20
PB Ratio	0.32
P/TBV Ratio	0.32
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 8.14, with a Debt / Equity ratio of 0.40.

Current Ratio	8.14
Quick Ratio	8.07
Debt / Equity	0.40
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-36.91

Financial Efficiency

Return on equity (ROE) is -65.08% and return on invested capital (ROIC) is -28.97%.

Return on Equity (ROE)	-65.08%
Return on Assets (ROA)	-26.20%
Return on Invested Capital (ROIC)	-28.97%
Return on Capital Employed (ROCE)	-40.23%
Revenue Per Employee	$14,441
Profits Per Employee	-$653,841
Employee Count	195
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -83.73% in the last 52 weeks. The beta is 0.91, so TCRX's price volatility has been similar to the market average.

Beta (5Y)	0.91
52-Week Price Change	-83.73%
50-Day Moving Average	2.05
200-Day Moving Average	4.49
Relative Strength Index (RSI)	29.10
Average Volume (20 Days)	442,737

Short Selling Information

The latest short interest is 1.90 million, so 3.36% of the outstanding shares have been sold short.

Short Interest	1.90M
Short Previous Month	2.23M
Short % of Shares Out	3.36%
Short % of Float	5.12%
Short Ratio (days to cover)	4.13

Income Statement

In the last 12 months, TCRX had revenue of $2.82 million and -$127.50 million in losses. Loss per share was -$2.25.

Revenue	2.82M
Gross Profit	-2.03M
Operating Income	-134.82M
Pretax Income	-96.80M
Net Income	-127.50M
EBITDA	-130.71M
EBIT	-134.82M
Loss Per Share	-$2.25

Balance Sheet

The company has $290.11 million in cash and $97.38 million in debt, giving a net cash position of $192.73 million or $3.41 per share.

Cash & Cash Equivalents	290.11M
Total Debt	97.38M
Net Cash	192.73M
Net Cash Per Share	$3.41
Equity (Book Value)	240.97M
Book Value Per Share	4.26
Working Capital	256.77M

Cash Flow

In the last 12 months, operating cash flow was -$110.82 million and capital expenditures -$3.83 million, giving a free cash flow of -$114.65 million.

Operating Cash Flow	-110.82M
Capital Expenditures	-3.83M
Free Cash Flow	-114.65M
FCF Per Share	-$2.03

Margins

Gross Margin	-72.09%
Operating Margin	-4,787.68%
Pretax Margin	-4,527.66%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TCRX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-18.32%
Shareholder Yield	n/a
Earnings Yield	-166.89%
FCF Yield	-150.07%

Analyst Forecast

The average price target for TCRX is $9.83, which is 628.15% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$9.83
Price Target Difference	628.15%
Analyst Consensus	Strong Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	121.82%
EPS Growth Forecast (5Y)	-35.07%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TCRX has an Altman Z-Score of -0.31 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.31
Piotroski F-Score	2